# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k122633   
B. Purpose for Submission: New device   
C. Measurand: d-Amphetamine, Secobarbital, Buprenorphine Glucuroide, Oxazepam, Benzoylecgonine, 3,4-methylenedioxymethamphetamine, Methamphetamine, Methadone, Moprhine, Oxycodone, Phencyclidine, Propoxyphene, Nortriptyline, 11-nor-∆9-Tetrahydrocannabinol9-carboxylic acid   
D. Type of Test: Qualitative lateral flow immunoassay   
E. Applicant: Branan Medical Corporation   
F. Proprietary and Established Names: ToxCup $\textsuperscript { \textregistered }$ Drug Screen Cup   
G. Regulatory Information:

<table><tr><td rowspan=1 colspan=1>ProductCode</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>Regulation Section</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>LDJ</td><td rowspan=1 colspan=1>I</td><td rowspan=1 colspan=1>862.3870 Cannabinoid test system</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr><tr><td rowspan=1 colspan=1>DIO</td><td rowspan=1 colspan=1>I</td><td rowspan=1 colspan=1>862.3250 Cocaine and cocaine metabolitetest system</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr><tr><td rowspan=1 colspan=1>DJG</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>862.3650 Opiate test system</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr><tr><td rowspan=1 colspan=1>DJC</td><td rowspan=1 colspan=1>I</td><td rowspan=1 colspan=1>862.3610 Methamphetamine test system</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr><tr><td rowspan=1 colspan=1>DKZ</td><td rowspan=1 colspan=1>I</td><td rowspan=1 colspan=1>862.3100 Amphetamine test system</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr><tr><td rowspan=1 colspan=1>LCM</td><td rowspan=1 colspan=1>unclassifed</td><td rowspan=1 colspan=1>Enzyme immunoassay Phencyclidine</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr><tr><td rowspan=1 colspan=1>JXM</td><td rowspan=1 colspan=1>I</td><td rowspan=1 colspan=1>862.3170 Benzodiazepine test system</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr><tr><td rowspan=1 colspan=1>DIS</td><td rowspan=1 colspan=1>Ⅱ</td><td rowspan=1 colspan=1>862.3150 Barbiturate test system</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr><tr><td rowspan=1 colspan=1>DJR</td><td rowspan=1 colspan=1>I</td><td rowspan=1 colspan=1>862.3620 Methadone test system</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr><tr><td rowspan=1 colspan=1>LFG</td><td rowspan=1 colspan=1>Ⅱ</td><td rowspan=1 colspan=1>862.3910 Tricyclic antidepressant drugstest system</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr><tr><td rowspan=1 colspan=1>JXN</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>862.3700 Propoxyphene test system</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr></table>

# H. Intended Use:

1. Intended use(s): See indications for use below.

2. Indications(s) for use:

The ToxCup Drug Screen Cup is an in vitro screening test for the rapid detection of multiple drugs and drug metabolites in human urine at or above the following cutoff concentration:

<table><tr><td rowspan=1 colspan=1>Abbreviation</td><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>Cutoff</td></tr><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>Amphetamine</td><td rowspan=1 colspan=1>500 ng/mL</td></tr><tr><td rowspan=1 colspan=1>BAR</td><td rowspan=1 colspan=1>Secobarbitol</td><td rowspan=1 colspan=1>300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>BUPG</td><td rowspan=1 colspan=1>Buprenorphine Glucuronide</td><td rowspan=1 colspan=1>10 ng/mL</td></tr><tr><td rowspan=1 colspan=1>BZO</td><td rowspan=1 colspan=1>Oxazepam</td><td rowspan=1 colspan=1>300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>COC</td><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>150 ng/mL</td></tr><tr><td rowspan=1 colspan=1>MDMA</td><td rowspan=1 colspan=1>3,4-methylenedioxymethamphetamine</td><td rowspan=1 colspan=1>500 ng/mL</td></tr><tr><td rowspan=1 colspan=1>MET</td><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500 ng/mL</td></tr><tr><td rowspan=1 colspan=1>MTD</td><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>OPI</td><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>OXY</td><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>100 ng/mL</td></tr><tr><td rowspan=1 colspan=1>PCP</td><td rowspan=1 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>25 ng/mL</td></tr><tr><td rowspan=1 colspan=1>PPX</td><td rowspan=1 colspan=1>Propoxyphene</td><td rowspan=1 colspan=1>300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>TCA</td><td rowspan=1 colspan=1>Nortriptyline</td><td rowspan=1 colspan=1>1000 ng/mL</td></tr><tr><td rowspan=1 colspan=1>THC</td><td rowspan=1 colspan=1>11-nor- 9-Tetrahydrocannabinol-9-carboxylic acid</td><td rowspan=1 colspan=1>50 ng/mL</td></tr></table>

These tests provide visual qualitative results and are intended for in vitro diagnostic use only. The ToxCup Drug Screen Cup is available in double drug analyte cassette dip format. It is intended for prescription point-of-care use and over-the-counter consumer use.

These tests provide only a preliminary test result and are the first step in a two-step process for detecting drugs of abuse in urine. The second step is confirming the results in a certified laboratory. For a quantitative result or to confirm preliminary positive results obtained by the ToxCup Drug Screen Cup, a more specific alternative method such as Gas Chromatography/Mass Spectrometry (GC/MS) must be used. Clinical consideration and professional judgment must be applied to any drug of abuse test result, particularly when a preliminary positive result is indicated.

3. Special conditions for use statement(s): For over-the counter use.

4. Special instrument requirements: Not Applicable

# I. Device Description:

This device is to be used with human urine samples. The tests are available in the cassette dip format. The cassette format consists of the ToxCup Drug Screen Cup test strips, a plastic cassette dip and a plastic cup base. The plastic cassette dip can hold up to 7 individual test strips. Each test strip can detect up to 2 drugs.

Each test strip consists of an absorbent pad used to deliver sample to the test strip, a drug antibody-colloidal gold conjugate pad, two stripes of drug protein conjugate known as Test regions (T) and a control stripe of goat anti-rabbit IgG antibody (C).

# J. Substantial Equivalence Information:

1. Predicate device name(s): Amedica Home Drug Test Cup

2. Predicate 510(k) number(s): k082898

3. Comparison with predicate:

<table><tr><td rowspan=1 colspan=3>Reagent Similarities and Differences</td></tr><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Candidate Device: ToxCup DrugScreen Cup (k122633)</td><td rowspan=1 colspan=1>Predicate Device:Amedica Home DrugTest Cup (k082898)</td></tr><tr><td rowspan=1 colspan=1>Intended/Indicationsfor Use</td><td rowspan=1 colspan=1>Screening Device</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Competitive immunoassay</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Results</td><td rowspan=1 colspan=1>Qualitative</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Human Urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Cut Off Value</td><td rowspan=1 colspan=1>THC: 50 ng/mLAmphetamine: 500 ng/mLSecobarbital: 300 ng/mLBuprenorphine Glucuronide: 10ng/mLBenzoylecgonine: 150 ng/mLMDMA: 500 ng/mLMethamphetamine: 500ng/mLMethadone: 300 ng/mLMorphine: 300 ng/mLPhencyclidine 25 ng/mLBenzodiazepines 300 ng/mLNortriptyline 1000 ng/mLOxycodone 100 ng/mLPropoxyphene 300 ng/mL</td><td rowspan=1 colspan=1>THC: 50 ng/mLAmphetamine: 1000ng/mLSecobarbital: 300 ng/mLMorphine: 300 ng/mLBenzodiazepines 300ng/mLMethadone: 300 ng/mLOxycodone 100 ng/mLMDMA: 500 ng/mLNortriptyline 1000 ng/mLPhencyclidine 25 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Configurations</td><td rowspan=1 colspan=1>Strip, Cassette</td><td rowspan=1 colspan=1>Card</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Over the Counter and PrescriptionUse</td><td rowspan=1 colspan=1>Over the Counter</td></tr><tr><td rowspan=1 colspan=1>Test Strip</td><td rowspan=1 colspan=1>Tests up to 14 drugs</td><td rowspan=1 colspan=1>Tests up to 12 drugs</td></tr><tr><td rowspan=1 colspan=1>MethodComparison Total% agreement</td><td rowspan=1 colspan=1>≥ 95%</td><td rowspan=1 colspan=1>≥ 93%</td></tr><tr><td rowspan=1 colspan=1>Storage</td><td rowspan=1 colspan=1>Sealed Pouch at15-30°C</td><td rowspan=1 colspan=1>Sealed pouch at 2-30°C</td></tr><tr><td rowspan=1 colspan=1>Reading Time</td><td rowspan=1 colspan=1>5-8 minutes</td><td rowspan=1 colspan=1>4-5 minutes</td></tr></table>

# K. Standard/ Guidance Document Referenced (if applicable):

• In Vitro Diagnostic Devices; Guidance for the Preparation of 510(k) Submission Premarket Submission and Labeling Recommendations for Drugs of Abuse Screening Tests, Draft Guidance

# L. Test Principle:

The tests are available in the cassette dip format. Each test strip consists of an absorbent pad used to deliver sample to the test strip, a drug antibody-colloidal gold conjugate pad, two stripes of drug protein conjugate known as Test regions (T) and a control stripe of goat antirabbit IgG antibody (C).

When the absorbent end of the test device is immersed into the urine sample, the urine is absorbed into the device by capillary action, mixes with the antibody-dye conjugate, and flows across the pre-coated membrane. When sample drug levels are zero or below the target cut off (the detection sensitivity of the test), antibody-dye conjugate binds to the drugprotein conjugate immobilized in the T region of the device. This produces a colored Test line, which regardless of its intensity, indicates a negative result.

When sample drug levels are at or above the target cutoff, the free drug in the binding sample binds to the antibody-dye conjugate preventing the antibody-dye conjugate from binding to the drug-protein conjugate immobilized in the T region of the device. This prevents the development of a distinct colored band in the test region, indicating a potentially positive result.

To serve as a procedure control, a colored line will appear at the C Region, if the test has been performed properly because of the antibody-dye conjugate binding to anti-rabbit IgG immobilized in the C Region of the device.

# M. Performance Characteristics (if/when applicable):

# 1. Analytical performance:

a. Precision/Reproducibility:

The precision study was performed by taking negative urine samples and spiking these with: $\pm 2 5$ , 50, 75, and $100 \%$ of the different cut-off values for each drug. The study was performed at three different point-of-care sites for a minimum of 10 days. Each of the three sites had one operator perform the studies on one lot of cups for a total of three lots studied. All samples were randomized and masked three lots drug screen cups were used. A summary of the results is presented in the tables below.

11-nor-9-Tetrahydrocannabinol-9-carboxylic acid $= \ 5 0 \ \mathrm { n g / m L }$ cut-off   

<table><tr><td colspan="1" rowspan="1">Site</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">-75%Cut-off</td><td colspan="1" rowspan="1">-50%Cut-off</td><td colspan="1" rowspan="1">-25%Cut-off</td><td colspan="1" rowspan="1">Cut-off</td><td colspan="1" rowspan="1">+25%Cut-off</td><td colspan="1" rowspan="1">+50%Cut-off</td><td colspan="1" rowspan="1">+75%Cut-off</td><td colspan="1" rowspan="1">+ 100%Cut-off</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td></tr><tr><td colspan="1" rowspan="1">Site1</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">14/1</td><td colspan="1" rowspan="1">6/9</td><td colspan="1" rowspan="1">2/13</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site2</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">7/8</td><td colspan="1" rowspan="1">1/14</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site3</td><td colspan="1" rowspan="1">120-0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">8/7</td><td colspan="1" rowspan="1">1/14</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site1</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">14/1</td><td colspan="1" rowspan="1">6/9</td><td colspan="1" rowspan="1">1/14</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site2</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">4/11</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site3</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">4/11</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr></table>

Morphine $\mathrm { ~  ~ { ~ \alpha ~ } ~ } = ~ 3 0 0 ~ \mathrm { n g / m L }$ cut-off   

<table><tr><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td></tr><tr><td rowspan=1 colspan=1>Site1</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>13/2</td><td rowspan=1 colspan=1>6/9</td><td rowspan=1 colspan=1>1/14</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr><tr><td rowspan=1 colspan=1>Site2</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>12/3</td><td rowspan=1 colspan=1>4/11</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr><tr><td rowspan=1 colspan=1>Site3</td><td rowspan=1 colspan=1>120-0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>14/1</td><td rowspan=1 colspan=1>4/11</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr></table>

Methamphetamine $= 5 0 0 ~ \mathrm { n g / m L }$ cut-off   

<table><tr><td colspan="1" rowspan="1">Site</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">-75%Cut-off</td><td colspan="1" rowspan="1">-50%Cut-off</td><td colspan="1" rowspan="1">-25%Cut-off</td><td colspan="1" rowspan="1">Cut-off</td><td colspan="1" rowspan="1">+25%Cut-off</td><td colspan="1" rowspan="1">+50%Cut-off</td><td colspan="1" rowspan="1">+75%Cut-off</td><td colspan="1" rowspan="1">+100%Cut-off</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td></tr><tr><td colspan="1" rowspan="1">Site1</td><td colspan="1" rowspan="1">105/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">7/8</td><td colspan="1" rowspan="1">1/14</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site2</td><td colspan="1" rowspan="1">105/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">8/7</td><td colspan="1" rowspan="1">1/13</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site3</td><td colspan="1" rowspan="1">105/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">10/5</td><td colspan="1" rowspan="1">1/14</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">-75%Cut-off</td><td colspan="1" rowspan="1">-50%Cut-off</td><td colspan="1" rowspan="1">-25%Cut-off</td><td colspan="1" rowspan="1">Cut-off</td><td colspan="1" rowspan="1">+25%Cut-off</td><td colspan="1" rowspan="1">+50%Cut-off</td><td colspan="1" rowspan="1">+75%Cut-off</td><td colspan="1" rowspan="1">+ 100%Cut-off</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td></tr><tr><td colspan="1" rowspan="1">Site1</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">13/2</td><td colspan="1" rowspan="1">6/9</td><td colspan="1" rowspan="1">1/14</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site2</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">5/10</td><td colspan="1" rowspan="1">1/14</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site3</td><td colspan="1" rowspan="1">120-0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">4/11</td><td colspan="1" rowspan="1">2/13</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr></table>

Oxazepam $= 3 0 0 ~ \mathrm { n g / m L }$ cut-off   

<table><tr><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td></tr><tr><td rowspan=1 colspan=1>Site1</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>5/10</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr><tr><td rowspan=1 colspan=1>Site2</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>3/12</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr><tr><td rowspan=1 colspan=1>Site3</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>4/11</td><td rowspan=1 colspan=1>1/14</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr></table>

Secobarbital $\mathrm { ~  ~ { ~ \alpha ~ } ~ } = ~ 3 0 0 ~ \mathrm { n g / m L }$ cut-off   

<table><tr><td colspan="1" rowspan="1">Site</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">-75%Cut-off</td><td colspan="1" rowspan="1">-50%Cut-off</td><td colspan="1" rowspan="1">-25%Cut-off</td><td colspan="1" rowspan="1">Cut-off</td><td colspan="1" rowspan="1">+25%Cut-off</td><td colspan="1" rowspan="1">+50%Cut-off</td><td colspan="1" rowspan="1">+75%Cut-off</td><td colspan="1" rowspan="1">+100%Cut-off</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td></tr><tr><td colspan="1" rowspan="1">Site1</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">14/1</td><td colspan="1" rowspan="1">6/9</td><td colspan="1" rowspan="1">2/13</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site2</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">7/8</td><td colspan="1" rowspan="1">1/14</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site3</td><td colspan="1" rowspan="1">120-0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">8/7</td><td colspan="1" rowspan="1">1/14</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">-75%Cut-off</td><td colspan="1" rowspan="1">-50%Cut-off</td><td colspan="1" rowspan="1">-25%Cut-off</td><td colspan="1" rowspan="1">Cut-off</td><td colspan="1" rowspan="1">+25%Cut-off</td><td colspan="1" rowspan="1">+50%Cut-off</td><td colspan="1" rowspan="1">+75%Cut-off</td><td colspan="1" rowspan="1">+ 100%Cut-off</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td></tr><tr><td colspan="1" rowspan="1">Site1</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">14/1</td><td colspan="1" rowspan="1">6/9</td><td colspan="1" rowspan="1">1/14</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site2</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">4/11</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site3</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">4/11</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr></table>

Buprenorphine Glucoronide $= 1 0 ~ \mathrm { { n g / m L } }$ cut-off   

<table><tr><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+ 100%Cut-off</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td></tr><tr><td rowspan=1 colspan=1>Site1</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>13/2</td><td rowspan=1 colspan=1>6/9</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr><tr><td rowspan=1 colspan=1>Site2</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>12/3</td><td rowspan=1 colspan=1>7/8</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr><tr><td rowspan=1 colspan=1>Site3</td><td rowspan=1 colspan=1>120-0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>14/1</td><td rowspan=1 colspan=1>9/6</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr></table>

Nortriptyline $= 1 0 0 0 \mathrm { n g / m L }$ cut-off   

<table><tr><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+ 100%Cut-off</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td></tr><tr><td rowspan=1 colspan=1>Site1</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>14/1</td><td rowspan=1 colspan=1>8/7</td><td rowspan=1 colspan=1>2/13</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr><tr><td rowspan=1 colspan=1>Site2</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>12/3</td><td rowspan=1 colspan=1>2/13</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr><tr><td rowspan=1 colspan=1>Site3</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>14/1</td><td rowspan=1 colspan=1>13/2</td><td rowspan=1 colspan=1>2/13</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr></table>

3,4-methylenedioxymethamphetamine $=$ $5 0 0 ~ \mathrm { { n g / m L } }$ cut-off   

<table><tr><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+ 100%Cut-off</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td></tr><tr><td rowspan=1 colspan=1>Site1</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>14/1</td><td rowspan=1 colspan=1>4/11</td><td rowspan=1 colspan=1>1/14</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr><tr><td rowspan=1 colspan=1>Site2</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>13/2</td><td rowspan=1 colspan=1>5/10</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr><tr><td rowspan=1 colspan=1>Site3</td><td rowspan=1 colspan=1>120-0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>7/8</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr></table>

Oxycodone $= 1 0 0 ~ \mathrm { { n g / m L } }$ cut-off   

<table><tr><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td><td rowspan=1 colspan=1>Neg/Pos</td></tr><tr><td rowspan=1 colspan=1>Site1</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>7/8</td><td rowspan=1 colspan=1>1/14</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr><tr><td rowspan=1 colspan=1>Site2</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>8/7</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr><tr><td rowspan=1 colspan=1>Site3</td><td rowspan=1 colspan=1>120/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>15/0</td><td rowspan=1 colspan=1>12/3</td><td rowspan=1 colspan=1>1/14</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td><td rowspan=1 colspan=1>0/15</td></tr></table>

Phencyclidine $= ~ 2 5 ~ \mathrm { n g / m L }$ cut-off   

<table><tr><td colspan="1" rowspan="1">Site</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">-75%Cut-off</td><td colspan="1" rowspan="1">-50%Cut-off</td><td colspan="1" rowspan="1">-25%Cut-off</td><td colspan="1" rowspan="1">Cut-off</td><td colspan="1" rowspan="1">+25%Cut-off</td><td colspan="1" rowspan="1">+50%Cut-off</td><td colspan="1" rowspan="1">+75%Cut-off</td><td colspan="1" rowspan="1">+100%Cut-off</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td></tr><tr><td colspan="1" rowspan="1">Site1</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">9/6</td><td colspan="1" rowspan="1">1/14</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site2</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">10/5</td><td colspan="1" rowspan="1">2/13</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site3</td><td colspan="1" rowspan="1">120-0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">10/5</td><td colspan="1" rowspan="1">2/13</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">-75%Cut-off</td><td colspan="1" rowspan="1">-50%Cut-off</td><td colspan="1" rowspan="1">-25%Cut-off</td><td colspan="1" rowspan="1">Cut-off</td><td colspan="1" rowspan="1">+25%Cut-off</td><td colspan="1" rowspan="1">+50%Cut-off</td><td colspan="1" rowspan="1">+75%Cut-off</td><td colspan="1" rowspan="1">+ 100%Cut-off</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td></tr><tr><td colspan="1" rowspan="1">Site1</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">14/1</td><td colspan="1" rowspan="1">4/11</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site2</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">13/2</td><td colspan="1" rowspan="1">2/13</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr><tr><td colspan="1" rowspan="1">Site3</td><td colspan="1" rowspan="1">120/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">15/0</td><td colspan="1" rowspan="1">13/2</td><td colspan="1" rowspan="1">5/10</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td><td colspan="1" rowspan="1">0/15</td></tr></table>

b. Linearity/assay reportable range:

Not Applicable, the assay is intended for qualitative use c. Traceability, Stability, Expected values (controls, calibrators, or methods):

Control standards are not supplied with this device; however, this device has internal process controls. A colored line appearing in the control region confirms sufficient sample volume and adequate membrane wicking. Users are informed that the test is invalid if a line fails to appear in the control region.

Professional users are informed in the labeling that external negative and positive urine controls should be used to initially test each new lot of product to ensure proper performance.

# Stability

Accelerated stability studies were conducted on three lots of the ToxCup $\textsuperscript { \textregistered }$ Drug Screen Tests. Protocols and acceptance criteria were found to be acceptable. The manufacturer claims an 18 month shelf life. Real time studies are on-going.

Read time stability was performed for the $\operatorname { T o x } \mathbf { C u p } \textcircled { \mathbf { R } }$ Drug Screen Tests. A drug-free urine sample was spiked with the appropriate drug at $\pm 2 5 \%$ , $50 \%$ , and $+ 2 0 0 \%$ of the cutoff. 20 replicates per level were tested at 2-10 minute intervals from 1-60 minutes. Data supports the recommended read time of 5-8 minutes.

d. Detection limit:

Not applicable, this is a qualitative assay.

# e. Analytical specificity:

Cross reactivity was established by spiking structurally related compounds into drug free urine and diluting each to determine the lowest concentration that produced a false positive result. Two devices were tested for each spiked urine solution. Results are expressed as the response equivalent to cutoff, which is the lowest interference concentration that produces a positive result. The percent cross-reactivity, expressed as $1 0 0 ^ { * }$ (cutoff/response equivalent to cutoff) is also presented below:

Structurally related:

<table><tr><td rowspan=1 colspan=1>11-nor-9-Tetrahydrocannabinol-9-carboxylic acid(Cutoff = 50 ng/ml)</td><td rowspan=1 colspan=1>ResponseEquivalent toCutoff (ng/mL)</td><td rowspan=1 colspan=1>% Cross Reactivity</td></tr><tr><td rowspan=1 colspan=1>Cannabinol</td><td rowspan=1 colspan=1>50000</td><td rowspan=1 colspan=1>0.1%</td></tr><tr><td rowspan=1 colspan=1>Cannabidiol</td><td rowspan=1 colspan=1>100000</td><td rowspan=1 colspan=1>0.05%</td></tr><tr><td rowspan=1 colspan=1>11-nor-Δ9-Tetrahydrocannabinol-9-carboxylic acid</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>11-nor-Δ8-Tetrahydrocannabinol-9-carboxylic acid</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>11-hydroxy-∆9-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>2500</td><td rowspan=1 colspan=1>2%</td></tr><tr><td rowspan=1 colspan=1>Δ8-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>7000</td><td rowspan=1 colspan=1>0.71%</td></tr><tr><td rowspan=1 colspan=1>Δ9-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>10500</td><td rowspan=1 colspan=1>0.48%</td></tr></table>

<table><tr><td colspan="1" rowspan="1">Benzoylecgonine(Cutoff = 150 ng/ml)</td><td colspan="1" rowspan="1">ResponseEquivalent toCutoff (ng/mL)</td><td colspan="1" rowspan="1">% Cross Reactivity</td></tr><tr><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Ecgonine</td><td colspan="1" rowspan="1">65500</td><td colspan="1" rowspan="1">0.23%</td></tr><tr><td colspan="1" rowspan="1">Morphine(Cutoff = 300 ng/ml)</td><td colspan="1" rowspan="1">ResponseEquivalent toCutoff (ng/mL)</td><td colspan="1" rowspan="1">% Cross Reactivity</td></tr><tr><td colspan="1" rowspan="1">6-Acetylmorphine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60%</td></tr><tr><td colspan="1" rowspan="1">6-Acetylcodeine</td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">50%</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Dihydrocodeine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60%</td></tr><tr><td colspan="1" rowspan="1">Ethyl Morphine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Heroin</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">300%</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">30%</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">75%</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Morphine-3-β-glururonide</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60%</td></tr><tr><td colspan="1" rowspan="1">Nalorphine</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">6%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Methamphetamine(Cutoff = 500 ng/ml)</td><td rowspan=1 colspan=1>ResponseEquivalent toCutoff (ng/mL)</td><td rowspan=1 colspan=1>% Cross Reactivity</td></tr><tr><td rowspan=1 colspan=1>Ephedrine</td><td rowspan=1 colspan=1>10000</td><td rowspan=1 colspan=1>5%</td></tr><tr><td rowspan=1 colspan=1>p-hydroxymethamphetamine</td><td rowspan=1 colspan=1>1750</td><td rowspan=1 colspan=1>28.57%</td></tr><tr><td rowspan=1 colspan=1>D,1-3,4-MDMA</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>50%</td></tr><tr><td rowspan=1 colspan=1>d-methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>1-methamphetamine</td><td rowspan=1 colspan=1>25000</td><td rowspan=1 colspan=1>2%</td></tr><tr><td rowspan=1 colspan=1>Procaine</td><td rowspan=1 colspan=1>50000</td><td rowspan=1 colspan=1>1%</td></tr><tr><td rowspan=1 colspan=1>d,1-3,4-MDEA</td><td rowspan=1 colspan=1>20000</td><td rowspan=1 colspan=1>2.5%</td></tr><tr><td rowspan=1 colspan=1>Trimethobenzamine</td><td rowspan=1 colspan=1>75000</td><td rowspan=1 colspan=1>0.67%</td></tr></table>

<table><tr><td colspan="1" rowspan="1">Amphetamine(Cutoff = 500 ng/ml)</td><td colspan="1" rowspan="1">ResponseEquivalent toCutoff (ng/mL)</td><td colspan="1" rowspan="1">% Cross Reactivity</td></tr><tr><td colspan="1" rowspan="1">1-Amphetamine</td><td colspan="1" rowspan="1">20000</td><td colspan="1" rowspan="1">2.5%</td></tr><tr><td colspan="1" rowspan="1">d-Amphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">D,1-3,4-methylenedioxyamphtamine(MDA)</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">33.3%</td></tr><tr><td colspan="1" rowspan="1">Phentermine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">50%</td></tr><tr><td colspan="1" rowspan="1">β-phenylethylamine</td><td colspan="1" rowspan="1">80000</td><td colspan="1" rowspan="1">0.63%</td></tr><tr><td colspan="1" rowspan="1">OxazepamCutoff= 300 ng/ml</td><td colspan="1" rowspan="1">ResponseEquivalent toCutoff (ng/mL)</td><td colspan="1" rowspan="1">% Cross Reactivity</td></tr><tr><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">200%</td></tr><tr><td colspan="1" rowspan="1">a-hydroxyalprazolam</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">600%</td></tr><tr><td colspan="1" rowspan="1">Bromazepam</td><td colspan="1" rowspan="1">800</td><td colspan="1" rowspan="1">37.5</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">3000</td><td colspan="1" rowspan="1">37.5%</td></tr><tr><td colspan="1" rowspan="1">Clonazepam</td><td colspan="1" rowspan="1">4000</td><td colspan="1" rowspan="1">7.5%</td></tr><tr><td colspan="1" rowspan="1">Clobazam</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">150%</td></tr><tr><td colspan="1" rowspan="1">Delorazepam</td><td colspan="1" rowspan="1">6000</td><td colspan="1" rowspan="1">5%</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">200%</td></tr><tr><td colspan="1" rowspan="1">Estazolam</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Flunitrazepam</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">30%</td></tr><tr><td colspan="1" rowspan="1">Flurazepam</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">20%</td></tr><tr><td colspan="1" rowspan="1">Lormetazepam</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">30%</td></tr><tr><td colspan="1" rowspan="1">Medazepam</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">15%</td></tr><tr><td colspan="1" rowspan="1">Nitrazepam</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">30%</td></tr><tr><td colspan="1" rowspan="1">Nordiazepam</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">300%</td></tr><tr><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Phenazepam</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">30%</td></tr><tr><td colspan="1" rowspan="1">Prazepam</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">30%</td></tr><tr><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">50%</td></tr><tr><td colspan="1" rowspan="1">Trazolam</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">20%</td></tr></table>

<table><tr><td colspan="1" rowspan="1">SecobarbitalCutoff= 300 ng/ml)</td><td colspan="1" rowspan="1">ResponseEquivalent toCutoff (ng/mL)</td><td colspan="1" rowspan="1">% Cross Reactivity</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">20%</td></tr><tr><td colspan="1" rowspan="1">Alphenal</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">75%</td></tr><tr><td colspan="1" rowspan="1">Aprobarbital</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">150%</td></tr><tr><td colspan="1" rowspan="1">Allobarbital</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Butabarbital</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">75%</td></tr><tr><td colspan="1" rowspan="1">Butethal</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">75%</td></tr><tr><td colspan="1" rowspan="1">Butalbital</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Barbital</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">75%</td></tr><tr><td colspan="1" rowspan="1">Secobarbital</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Pentobarbital</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">75%</td></tr><tr><td colspan="1" rowspan="1">Phenobarbital</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">75%</td></tr><tr><td colspan="1" rowspan="1">MethadoneCutoff= 300 ng/ml</td><td colspan="1" rowspan="1">ResponseEquivalent toCutoff (ng/mL)</td><td colspan="1" rowspan="1">% Cross Reactivity</td></tr><tr><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">0.6%</td></tr><tr><td colspan="1" rowspan="1">w-Ethylidene-1,5 Dimethyl-1,3Diphenylapyrolidine</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">0.6%</td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Pheniramine</td><td colspan="1" rowspan="1">75,000</td><td colspan="1" rowspan="1">0.4%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Buprenorphine GlucuronideCutoff= 10 ng/ml</td><td rowspan=1 colspan=1>ResponseEquivalent toCutoff (ng/mL)</td><td rowspan=1 colspan=1>% Cross Reactivity</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>10%</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine Glucuronide</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Norbuprenorphine</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>10%</td></tr><tr><td rowspan=1 colspan=1>Norbuprenorphine Glucuronide</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>10%</td></tr></table>

<table><tr><td colspan="1" rowspan="1">NortriptylineCutoff= 1000 ng/ml</td><td colspan="1" rowspan="1">ResponseEquivalent toCutoff (ng/mL)</td><td colspan="1" rowspan="1">% Cross Reactivity</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">7500</td><td colspan="1" rowspan="1">13.33%</td></tr><tr><td colspan="1" rowspan="1">Cyclobenzaprine</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">66.67%</td></tr><tr><td colspan="1" rowspan="1">Desipramine</td><td colspan="1" rowspan="1">750</td><td colspan="1" rowspan="1">133.33%</td></tr><tr><td colspan="1" rowspan="1">Doxepin</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">750</td><td colspan="1" rowspan="1">133.33%</td></tr><tr><td colspan="1" rowspan="1">Nordoxepin</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Perphenazine</td><td colspan="1" rowspan="1">50000</td><td colspan="1" rowspan="1">2%</td></tr><tr><td colspan="1" rowspan="1">Promazine</td><td colspan="1" rowspan="1">10,000</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">Protriptyline</td><td colspan="1" rowspan="1">350</td><td colspan="1" rowspan="1">285.7%</td></tr><tr><td colspan="1" rowspan="1">Trimipramine</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">66.67%</td></tr><tr><td colspan="1" rowspan="1">3,4methylenediozymethamphetamineCutoff= 500 ng/ml</td><td colspan="1" rowspan="1">ResponseEquivalent toCutoff (ng/mL)</td><td colspan="1" rowspan="1">% Cross Reactivity</td></tr><tr><td colspan="1" rowspan="1">d,1-3,4-MDA</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">25%</td></tr><tr><td colspan="1" rowspan="1">d,1-3,4-MDEA</td><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">200%</td></tr><tr><td colspan="1" rowspan="1">d,1-3,4-MDMA</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">d-Methamphetamine</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">1%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>OxycodoneCutoff= 100 ng/ml</td><td rowspan=1 colspan=1>ResponseEquivalent toCutoff (ng/mL)</td><td rowspan=1 colspan=1>% Cross Reactivity</td></tr><tr><td rowspan=1 colspan=1>Codeine</td><td rowspan=1 colspan=1>5000</td><td rowspan=1 colspan=1>2%</td></tr><tr><td rowspan=1 colspan=1>Dihydrocodeine</td><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>5%</td></tr><tr><td rowspan=1 colspan=1>6-Acetylcodeine</td><td rowspan=1 colspan=1>15,000</td><td rowspan=1 colspan=1>0.67%</td></tr><tr><td rowspan=1 colspan=1>Hyrdrocodone</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>33.3%</td></tr><tr><td rowspan=1 colspan=1>Oxymorphone</td><td rowspan=1 colspan=1>3000</td><td rowspan=1 colspan=1>3.3%</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Hydromorphone</td><td rowspan=1 colspan=1>25,000</td><td rowspan=1 colspan=1>0.4%</td></tr><tr><td rowspan=1 colspan=1>Ethylmorphine</td><td rowspan=1 colspan=1>5000</td><td rowspan=1 colspan=1>2%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>PhencyclidineCutoff= 25 ng/ml</td><td rowspan=1 colspan=1>ResponseEquivalent toCutoff (ng/mL)</td><td rowspan=1 colspan=1>% Cross Reactivity</td></tr><tr><td rowspan=1 colspan=1>4-Hydroxy Phencyclidine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>5%</td></tr><tr><td rowspan=1 colspan=1>Metaphit</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>5%</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine Morpholine</td><td rowspan=1 colspan=1>50,000</td><td rowspan=1 colspan=1>0.05%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>PropoxypheneCutoff= 300 ng/ml</td><td rowspan=1 colspan=1>ResponseEquivalent toCutoff (ng/mL)</td><td rowspan=1 colspan=1>% Cross Reactivity</td></tr><tr><td rowspan=1 colspan=1>Propoxyphene</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Norpropoxyphene</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>60%</td></tr></table>

Structurally Un-related Compounds:

This study was performed by spiking structurally unrelated compounds and endogenous substances up to concentration of $1 0 0 ~ \mu \mathrm { g / m L }$ into urine samples containing drug at $\pm$ $50 \%$ of the respective drug cutoff concentrations. Testing was performed for on two devices for each urine control. The following compounds showed no interference when tested at the $\pm 5 0 \%$ drug concentration.

# Acetaminophen Acetone

Albumin   
Acetylsalicyclic Acid   
Amoxapine   
Amoxicillin   
Ampicillin   
Ascorbic Acid   
Apomorphine   
Aspartame   
Atropine Sulfate   
Benzilic Acid   
Benzoicaine   
Benzoic Acid   
Bilirubin

Brompheniramine

Benzphetamine Cholesterol Caffeine

$( + / - )$ Chlorpheniramine   
Chlorpromazine   
Chlorquine Diphosphase   
Cortisone   
Cotinine   
Creatinine   
Creatine HCl   
Deoxycorticosterone   
acetate   
Dextromethorphan   
Diphenydramine   
Dopamine   
4-Dimethylaminotipyrine   
Ecgonine methyl ester   
(-) Epinephrine   
b- Estradiol   
Estrone-3-sulfate   
potassium salt   
Ethanol   
Ethyl-p-aminobenzoate   
Erythromycin   
Furosemide   
Gentisic acid   
Glutethimide   
Guaiaicol Glyceryl   
Ether   
D- $\cdot ( + )$ -glucose   
Hemoglobin   
Hippuric Acid   
Hydrochlorthiazide   
Hydrocortisone   
Ibuprofen   
$( + / - )$ -Isoproterenol   
Ketamine HCl   
Lidocaine   
Meperidine   
Methylphenamine   
Methaqualone   
2-Methylamine  
Propiophenone HCl   
(1R,2S)- $\cdot ( + )$ -N-Methyl  
Ephedrine   
Methylphenidate   
Nalidixic acid

Naloxone Naproxen Niacinamide S (-)-Nicotine Norepinephrine Norethinodrone Oxalic Acid

Oxolinic Acid Papaverine Penicillin-G Pentazocaine Phenothiazine Phenylephrine Prednisone Promethazine

d-Pseudophedrine   
Pyrrolidine   
Quinidine   
Quinine   
Ranitidine

Riboflavin Salicylic Acid

Serotonin   
Sodium Chloride   
Sulfamethazine   
Sulindac   
Tetracycline   
Thiamine   
Thioridazine   
Trifluoperazine   
Tryptamine   
d,l-Tryptophan   
Tyramine   
d,l-Tyrosine   
Uric Acid

Verapamil

Zomepirac   
Cocaine   
Setraline   
Ecgonine Methyl   
Ester   
Amitripytiline   
Ephedrine   
pheniramine   
$\beta$ -phenylethylamine   
procaine

The $\mathsf { p H }$ of a drug-free urine pool was adjusted to pH 3, $\mathsf { p H } 3 . 5$ , pH 4, pH 4.5, pH 5, $\mathsf { p H } 5 . 5$ , pH 6, $\mathsf { p H } 6 . 5$ , pH 7, pH 7.5, pH 8, $\mathsf { p H } 8 . 5$ or $\mathrm { p H } 9$ ; the urine was spiked with $\pm 5 0 \%$ of the cut-off concentration for each drug and two replicates were tested for each test. Altering the $\mathsf { p H }$ of the urine sample did not affect the accuracy of any of the test results.

The specific gravity of a drug-free urine pool was measured by obtaining urine samples with specific gravities of 1.005, 1.010, 1.020, and 1.030 and spiking with $\pm$ $50 \%$ of the cut-off concentration of the cut-off concentration for each drug and two replicates were tested for each test. Altering the specific gravity of the urine sample did not affect the accuracy of any of the test results.

f. Assay cut-off:

Characterization of how the device performs analytically around the claimed cutoff concentration appears in the precision section, M1.a, above.

2. Comparison studies:

a. Method comparison with predicate device:

The method comparison study was conducted to evaluate the performance of the device for detection of the different analytes at one point of care site using blind labeled urine samples and one lot of ToxCup Drug Screen Cups. For each drug test, at least 40 unaltered positive clinical samples and 40 unaltered negative clinical samples with known GC/MS or LC/MS values were tested. At least $10 \%$ of these samples had drug concentrations within the range of cutoff to $+ 5 0 \%$ cutoff. For the phencyclidine test, four diluted urine samples were used in the study. The results of the studies are presented below:

<table><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>′</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegativebyGC/MS(lessthan50%)</td><td rowspan=1 colspan=1>NearCutoffNegativebyGC/MS(between50%andcutoff)</td><td rowspan=1 colspan=1>NearCutoffPositivebyGC/MS(betweencutoffand50%)</td><td rowspan=1 colspan=1>HighpositivebyGC/MS(greaterthan40%</td><td rowspan=1 colspan=1>PercentAgreement</td></tr><tr><td rowspan=2 colspan=1>Amphetamine</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>95.1%</td></tr><tr><td rowspan=2 colspan=1>Oxazepam</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>92.5%</td></tr><tr><td rowspan=2 colspan=1>Secobarbital</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>33</td><td rowspan=1 colspan=1>95.1%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>97.5%</td></tr><tr><td rowspan=2 colspan=1>Methadone</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>97.5%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=2 colspan=1>BuprenorphineGlucuronide</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>97.7%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>97.5%</td></tr><tr><td rowspan=2 colspan=1>Nortriptyline</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>27</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>92.7%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=2 colspan=1>3,4 methylenediozy-Methamphetamine</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>97.7%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>97.5%</td></tr><tr><td rowspan=2 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>95.2%</td></tr><tr><td rowspan=2 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>95.1%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=2 colspan=1>Propoxyphene</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=2 colspan=1>11-nor-9-Tetrahydrocannabinol-9-carboxylic acid</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>35</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>97.7%</td></tr><tr><td rowspan=2 colspan=1>Morphine</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>34</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>92.5%</td></tr><tr><td rowspan=2 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>67</td><td rowspan=1 colspan=1>96%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=2 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>37</td><td rowspan=1 colspan=1>97.6%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>92.7%</td></tr></table>

The discordant results are listed in the table below.

<table><tr><td colspan="1" rowspan="1">Cutoff value(ng/mL)</td><td colspan="1" rowspan="1">Assay(POS/NEG)</td><td colspan="2" rowspan="1">Drug Metabolite GC/MS value (ng/mL)</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Drug/Metabolite</td><td colspan="1" rowspan="1">GC/MS value(ng/mL)</td></tr><tr><td colspan="1" rowspan="1">THC 50</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">11-Δ9-THC-COOH</td><td colspan="1" rowspan="1">36</td></tr><tr><td colspan="1" rowspan="1">Cocaine 150</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">120</td></tr><tr><td colspan="1" rowspan="1">Cocaine 150</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">138</td></tr><tr><td colspan="1" rowspan="1">Cocaine 150</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">140</td></tr><tr><td colspan="1" rowspan="1">Cocaine 150</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">194</td></tr><tr><td colspan="1" rowspan="1">Opiate 300</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">196</td></tr><tr><td colspan="1" rowspan="1">Opiate 300</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">251</td></tr><tr><td colspan="1" rowspan="1">Opiate 300</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">291</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">d-Methamphetamine</td><td colspan="1" rowspan="1">544</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">d-Methamphetamine</td><td colspan="1" rowspan="1">652</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">d-Methamphetamine</td><td colspan="1" rowspan="1">677</td></tr><tr><td colspan="1" rowspan="1">Amphetamine 500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">d-Amphetamine</td><td colspan="1" rowspan="1">395</td></tr><tr><td colspan="1" rowspan="1">Amphetamine 500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">d-Amphetamine</td><td colspan="1" rowspan="1">405</td></tr><tr><td colspan="1" rowspan="1">Benzodiazepine 300</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">132</td></tr><tr><td colspan="1" rowspan="1">Benzodiazepine 300</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">224</td></tr><tr><td colspan="1" rowspan="1">Benzodiazepine 300</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">268.4</td></tr><tr><td colspan="1" rowspan="1">Barbiturate 300</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Butalbital</td><td colspan="1" rowspan="1">202</td></tr><tr><td colspan="1" rowspan="1">Barbiturate 300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Butalbital</td><td colspan="1" rowspan="1">311</td></tr><tr><td colspan="1" rowspan="1">Barbiturate 300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Butalbital</td><td colspan="1" rowspan="1">357</td></tr><tr><td colspan="1" rowspan="1">Methadone 300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">304.8</td></tr><tr><td colspan="1" rowspan="1">Buprenorphine 10</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">BuprenorphineGlucuronide</td><td colspan="1" rowspan="1">8.2</td></tr><tr><td colspan="1" rowspan="1">Buprenorphine 10</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">BuprenorphineGlucuronide</td><td colspan="1" rowspan="1">11</td></tr><tr><td colspan="1" rowspan="1">TricyclicAntidepressants 1000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">1018</td></tr><tr><td colspan="1" rowspan="1">TricyclicAntidepressants 1000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">1065</td></tr><tr><td colspan="1" rowspan="1">TricyclicAntidepressants 1000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">1176</td></tr><tr><td colspan="1" rowspan="1">3,4 methylenediozy-Methamphetamine</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">3,4 methylenediozy-Methamphetamine</td><td colspan="1" rowspan="1">320</td></tr><tr><td colspan="1" rowspan="1">3,4 methylenediozy-Methamphetamine</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">3,4 methylenediozy-Methamphetamine</td><td colspan="1" rowspan="1">505</td></tr><tr><td colspan="1" rowspan="1">Oxycodone 100</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">54.7</td></tr><tr><td colspan="1" rowspan="1">Oxycodone 100</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">79.3</td></tr><tr><td colspan="1" rowspan="1">Phencyclidine 25</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Phencyclidine</td><td colspan="1" rowspan="1">29</td></tr><tr><td colspan="1" rowspan="1">Phencyclidine 25</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Phencyclidine</td><td colspan="1" rowspan="1">31</td></tr><tr><td colspan="1" rowspan="1">Propoxyphene 300</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Propoxyphene</td><td colspan="1" rowspan="1">273.1</td></tr><tr><td colspan="1" rowspan="1">Propoxyphene 300</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Propoxyphene</td><td colspan="1" rowspan="1">278</td></tr></table>

A lay-user study was performed to assess the suitability of the device for home use. Seven drug-free urine sample pools were spiked to $0 , \pm 2 5 \% , \pm 5 0 \% , \pm 7 5 \%$ of the cutoff of target drug. These concentrations were confirmed by GC/MS and one lot of ToxCup Drug Screen Cup was tested. The testing was performed at three sites by 153 blinded consumers divided between three sites (a minimum of 45 participants per site). Each participant received the package inset, 1-3 blinded samples, and 1-3 ToxCup Drug Screen Cups. The lay persons test result was compared to the GC/MS result to demonstrate accuracy by lay-users.

The participant’s ages ranged from 18-over 55 and there were slightly more males than females. They come from a variety of career and education backgrounds. All participants stated that the ToxCup Drug Screen Cup was easy to use, the test results were easy to read and the instructions for confirmation of the test were easy to understand.

Additionally, a Flesh-Kincaid reading analysis revealed that both package inserts had a reading grade level of 7.

The following are the results of the lay-user study pooled together from all three sites:

11-nor-9-Tetrahydrocannabinol-9-carboxylic acid   

<table><tr><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>NumberofSamples</td><td rowspan=1 colspan=1>11-nor-9-Tetrahydrocannabinol-9-carboxylic acidGS/MS Concentration(ng/mL)</td><td rowspan=1 colspan=1>Lay personresults:Pos/Neg</td><td rowspan=1 colspan=1>Percentage ofCorrectResults</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0/210</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>12.4</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>26.7</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>37.4</td><td rowspan=1 colspan=1>5/25</td><td rowspan=1 colspan=1>83.0</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>62.9</td><td rowspan=1 colspan=1>27/3</td><td rowspan=1 colspan=1>90.0</td></tr><tr><td rowspan=1 colspan=1>+50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>76.5</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>86.4</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr></table>

Benzoylecgonine   

<table><tr><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>NumberofSamples</td><td rowspan=1 colspan=1>BenzoylecgonineGS/MSConcentration(ng/mL)</td><td rowspan=1 colspan=1>Lay personresults:Pos/Neg</td><td rowspan=1 colspan=1>Percentage ofCorrect Results</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0/210</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>37.5</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>79</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>119</td><td rowspan=1 colspan=1>4/26</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>198</td><td rowspan=1 colspan=1>26/4</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>227</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>236</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr></table>

Morphine   

<table><tr><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>NumberofSamples</td><td rowspan=1 colspan=1>MorphineGS/MSConcentration(ng/mL)</td><td rowspan=1 colspan=1>Lay personresults:Pos/Neg</td><td rowspan=1 colspan=1>Percentage ofCorrect Results</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0/210</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>129</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>5/25</td><td rowspan=1 colspan=1>83.0</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>322</td><td rowspan=1 colspan=1>27/3</td><td rowspan=1 colspan=1>90.0</td></tr><tr><td rowspan=1 colspan=1>+50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>484</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>475</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr></table>

Methamphetamine   

<table><tr><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>NumberofSamples</td><td rowspan=1 colspan=1>MethamphetamineGS/MSConcentration(ng/mL)</td><td rowspan=1 colspan=1>Lay personresults:Pos/Neg</td><td rowspan=1 colspan=1>Percentage ofCorrect Results</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0/210</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>130</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>266</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>413</td><td rowspan=1 colspan=1>4/26</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>586</td><td rowspan=1 colspan=1>26/4</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>811</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>944</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr></table>

Amphetamine   

<table><tr><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>NumberofSamples</td><td rowspan=1 colspan=1>AmphetamineGS/MSConcentration(ng/mL)</td><td rowspan=1 colspan=1>Lay personresults:Pos/Neg</td><td rowspan=1 colspan=1>Percentage ofCorrect Results</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0/210</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>133</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>280</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>389</td><td rowspan=1 colspan=1>4/26</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>663</td><td rowspan=1 colspan=1>26/4</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>740</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>939</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr></table>

Oxazepam   

<table><tr><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>NumberofSamples</td><td rowspan=1 colspan=1>OxazepamGS/MSConcentration(ng/mL)</td><td rowspan=1 colspan=1>Lay personresults:Pos/Neg</td><td rowspan=1 colspan=1>Percentage ofCorrect Results</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0/210</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>82</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>245</td><td rowspan=1 colspan=1>5/25</td><td rowspan=1 colspan=1>83.0</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>403</td><td rowspan=1 colspan=1>26/4</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>465</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>535</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr></table>

Secobarbital   

<table><tr><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>NumberofSamples</td><td rowspan=1 colspan=1>SecobarbitalGS/MSConcentration(ng/mL)</td><td rowspan=1 colspan=1>Lay personresults:Pos/Neg</td><td rowspan=1 colspan=1>Percentage ofCorrect Results</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0/210</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>77</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>133</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>235</td><td rowspan=1 colspan=1>4/26</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>333</td><td rowspan=1 colspan=1>26/4</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>448</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>489</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr></table>

Methadone   

<table><tr><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>NumberofSamples</td><td rowspan=1 colspan=1>MethadoneGS/MSConcentration(ng/mL)</td><td rowspan=1 colspan=1>Lay personresults:Pos/Neg</td><td rowspan=1 colspan=1>Percentage ofCorrect Results</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0/210</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>78.7</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>165</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>217</td><td rowspan=1 colspan=1>4/26</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>366</td><td rowspan=1 colspan=1>25/5</td><td rowspan=1 colspan=1>83.0</td></tr><tr><td rowspan=1 colspan=1>+50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>480</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>547</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr></table>

Buprenorphine Glucuronide   

<table><tr><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>NumberofSamples</td><td rowspan=1 colspan=1>BuprenorphineGlucuronideGS/MSConcentration(ng/mL)</td><td rowspan=1 colspan=1>Lay personresults:Pos/Neg</td><td rowspan=1 colspan=1>Percentage ofCorrect Results</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0/210</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>4.5</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>5/25</td><td rowspan=1 colspan=1>83.0</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>12.3</td><td rowspan=1 colspan=1>29/1</td><td rowspan=1 colspan=1>97.0</td></tr><tr><td rowspan=1 colspan=1>+50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>15.3</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr></table>

Nortriptyline   

<table><tr><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>NumberofSamples</td><td rowspan=1 colspan=1>NortriptylineGS/MSConcentration(ng/mL)</td><td rowspan=1 colspan=1>Lay personresults:Pos/Neg</td><td rowspan=1 colspan=1>Percentage ofCorrect Results</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0/210</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>222</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>436</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>723</td><td rowspan=1 colspan=1>4/26</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>1105</td><td rowspan=1 colspan=1>26/4</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>1508</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>1761</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr></table>

3,4 methylenediozy-Methamphetamine   

<table><tr><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>NumberofSamples</td><td rowspan=1 colspan=1>3,4methylenediozy-MethamphetamineGS/MSConcentration(ng/mL)</td><td rowspan=1 colspan=1>Lay personresults:Pos/Neg</td><td rowspan=1 colspan=1>Percentage ofCorrect Results</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0/210</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>130</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>256</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>382</td><td rowspan=1 colspan=1>4/26</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>626</td><td rowspan=1 colspan=1>28/2</td><td rowspan=1 colspan=1>93.0</td></tr><tr><td rowspan=1 colspan=1>+50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>838</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>917</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr></table>

Oxycodone   

<table><tr><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>NumberofSamples</td><td rowspan=1 colspan=1>OxycodoneGS/MSConcentration(ng/mL)</td><td rowspan=1 colspan=1>Lay personresults:Pos/Neg</td><td rowspan=1 colspan=1>Percentage ofCorrect Results</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0/210</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>27.8</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>82</td><td rowspan=1 colspan=1>4/26</td><td rowspan=1 colspan=1>80.0</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>27/3</td><td rowspan=1 colspan=1>90.0</td></tr><tr><td rowspan=1 colspan=1>+50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>145</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>178</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr></table>

Phencyclidine   

<table><tr><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>NumberofSamples</td><td rowspan=1 colspan=1>PhencyclidineGS/MSConcentration(ng/mL)</td><td rowspan=1 colspan=1>Lay personresults:Pos/Neg</td><td rowspan=1 colspan=1>Percentage ofCorrect Results</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0/210</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>6.9</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>13.7</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>17.2</td><td rowspan=1 colspan=1>4/26</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>29.2</td><td rowspan=1 colspan=1>25/5</td><td rowspan=1 colspan=1>83.0</td></tr><tr><td rowspan=1 colspan=1>+50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>38.7</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>46.3</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr></table>

Propoxyphene   

<table><tr><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>NumberofSamples</td><td rowspan=1 colspan=1>PropoxypheneGS/MSConcentration(ng/mL)</td><td rowspan=1 colspan=1>Lay personresults:Pos/Neg</td><td rowspan=1 colspan=1>Percentage ofCorrect Results</td></tr><tr><td rowspan=1 colspan=1>-100% ofthe Cut-off</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0/210</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>74</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>153</td><td rowspan=1 colspan=1>0/30</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>204</td><td rowspan=1 colspan=1>4/26</td><td rowspan=1 colspan=1>87.0</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>337</td><td rowspan=1 colspan=1>28/2</td><td rowspan=1 colspan=1>93.0</td></tr><tr><td rowspan=1 colspan=1>+50 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>424</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75 %Cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>506</td><td rowspan=1 colspan=1>30/0</td><td rowspan=1 colspan=1>100</td></tr></table>

The overall percent agreement between the Lay person and the GC/MS method was:

<table><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>OverallPercentAgreement</td></tr><tr><td rowspan=1 colspan=1>11-nor- 9-Tetrahydrocannabinol-9-carboxylic acid</td><td rowspan=1 colspan=1>96.1%</td></tr><tr><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>96.3%</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>96.1%</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>96.3%</td></tr><tr><td rowspan=1 colspan=1>Amphetamine</td><td rowspan=1 colspan=1>95.2%</td></tr><tr><td rowspan=1 colspan=1>Oxazepam</td><td rowspan=1 colspan=1>95.7%</td></tr><tr><td rowspan=1 colspan=1>Secobarbitol</td><td rowspan=1 colspan=1>96.3%</td></tr><tr><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>95.7%</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine Glucuronide</td><td rowspan=1 colspan=1>97.1%</td></tr><tr><td rowspan=1 colspan=1>Nortriptyline</td><td rowspan=1 colspan=1>96.3%</td></tr><tr><td rowspan=1 colspan=1>3,4-methylenedioxymethamphetamine</td><td rowspan=1 colspan=1>97.1%</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>95.7%</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>94.7%</td></tr><tr><td rowspan=1 colspan=1>Propoxyphene</td><td rowspan=1 colspan=1>96.1%</td></tr></table>

b. Matrix comparison: Not applicable.

3. Clinical studies:

a. Clinical Sensitivity: Not Applicable

b. Clinical specificity: Not Applicable

c. Other clinical supportive data (when a. and b. are not applicable): Not Applicable

4. Clinical cut-off: Not Applicable

5. Expected values/Reference range Specific ranges for each analyte/methodology are listed in the package insert.

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.